Samedy Ouk

3.4k total citations · 1 hit paper
11 papers, 2.1k citations indexed

About

Samedy Ouk is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Samedy Ouk has authored 11 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Samedy Ouk's work include NF-κB Signaling Pathways (4 papers), Hormonal and reproductive studies (2 papers) and Synthesis and biological activity (2 papers). Samedy Ouk is often cited by papers focused on NF-κB Signaling Pathways (4 papers), Hormonal and reproductive studies (2 papers) and Synthesis and biological activity (2 papers). Samedy Ouk collaborates with scholars based in United States and Italy. Samedy Ouk's co-authors include Chris Tran, John Wongvipat, Michael E. Jung, Charles L. Sawyers, Dongwon Yoo, Derek S. Welsbie, Andrew Kwon, Tomasz M. Beer, Celestia S. Higano and Howard I. Scher and has published in prestigious journals such as Science, Blood and Cancer Research.

In The Last Decade

Samedy Ouk

11 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer

2009 1.7k citations Chris Tran, Samedy Ouk et al. Science profile →

Peers

Countries citing papers authored by Samedy Ouk

Since Specialization

Citations

This map shows the geographic impact of Samedy Ouk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samedy Ouk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samedy Ouk more than expected).

Fields of papers citing papers by Samedy Ouk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samedy Ouk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samedy Ouk. The network helps show where Samedy Ouk may publish in the future.

Co-authorship network of co-authors of Samedy Ouk

This figure shows the co-authorship network connecting the top 25 collaborators of Samedy Ouk. A scholar is included among the top collaborators of Samedy Ouk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samedy Ouk. Samedy Ouk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Targeted Lymphoma Therapy Using a Gold Nanoframework-Based Drug Delivery System 2023 ·ACS Applied Materials & Interfaces ·Manpreet Bariana, Beilu Zhang, Jingyu Sun, (unknown), Jinping Wang, (unknown), (unknown), (unknown), Samedy Ouk, Hsiou‐Chi Liou, Ming Tan, Hongjun Wang, Johannes L. Zakrzewski	10
2	Inhibition of NF-κB DNA Binding Suppresses Myeloma Growth via Intracellular Redox and Tumor Microenvironment Modulation 2022 ·Molecular Cancer Therapeutics ·Manpreet Bariana, (unknown), (unknown), Samedy Ouk, Hsiou‐Chi Liou, (unknown), Iriana Colorado, Rena Feinman, (unknown), David S. Siegel, Glenn Heller, Andrea Z. Tuckett, Patrizia Mondello, Johannes L. Zakrzewski	4
3	Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor 2017 ·Haematologica ·Tiziana Vaisitti, Federica Gaudino, Samedy Ouk, (unknown), Nicoletta Vitale, Sara Serra, Francesca Arruga, Johannes L. Zakrzewski, Hsiou‐Chi Liou, John N. Allan, Richard R. Furman, Silvia Deaglio	35
4	Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses 2016 ·Cancer Research ·Yusuke Shono, Andrea Z. Tuckett, Hsiou‐Chi Liou, Ekaterina Doubrovina, Enrico Derenzini, Samedy Ouk, Jennifer J. Tsai, Odette M. Smith, Emily R. Levy, Fabiana M. Kreines, Carly G.K. Ziegler, (unknown), Mikhail Doubrovin, Glenn Heller, Anas Younes, Richard J. O’Reilly, Marcel R.M. van den Brink, Johannes L. Zakrzewski	33
5	A Small-Molecule c-Rel Inhibitor Reduces Alloactivation of T Cells without Compromising Antitumor Activity 2014 ·Cancer Discovery ·Yusuke Shono, Andrea Z. Tuckett, Samedy Ouk, Hsiou‐Chi Liou, Grégoire Altan‐Bonnet, Jennifer J. Tsai, Jennifer E. Oyler, Odette M. Smith, Mallory L. West, Natalie V. Singer, Ekaterina Doubrovina, Dmitry Pankov, (unknown), Gëorge F. Murphy, Cecilia Lezcano, Chen Liu, Richard J. O’Reilly, Marcel R.M. van den Brink, Johannes L. Zakrzewski	42
6	Targeted Therapy of B Cell Lymphoma with a Direct Inhibitor of the NF-κB Subunit c-Rel 2014 ·Blood ·Yusuke Shono, Andrea Z. Tuckett, Hsiou‐Chi Liou, Samedy Ouk, Ekaterina Doubrovina, Mikhail Doubrovin, Enrico Derenzini, (unknown), Jennifer J. Tsai, Odette M. Smith, Anas Younes, Richard J. O’Reilly, Marcel R.M. van den Brink, Johannes L. Zakrzewski	1
7	6-Benzylamino 4-oxo-1,4-dihydro-1,8-naphthyridines and 4-oxo-1,4-dihydroquinolines as HIV integrase inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Johnny Nagasawa, Jenny Z. Song, Huanming Chen, (unknown), (unknown), Samedy Ouk, Bettina Gröschel, Virginia F. Borges, Voon Ong, Li‐Tain Yeh, Jean‐Luc Girardet, Jean‐Michel Vernier, Anneke K. Raney, Anthony B. Pinkerton	22
8	Structure−Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC) 2010 ·Journal of Medicinal Chemistry ·Michael E. Jung, Samedy Ouk, Dongwon Yoo, Charles L. Sawyers, Charlie Chen, Chris Tran, John Wongvipat	206
9	Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer breakdown → 2009 ·Science ·Chris Tran, Samedy Ouk, Nicola J. Clegg, Yu Chen, Philip A. Watson, Vivek Arora, John Wongvipat, Peter Smith‐Jones, Dongwon Yoo, Andrew Kwon, Teresa Wasielewska, Derek S. Welsbie, (unknown), Celestia S. Higano, Tomasz M. Beer, David T. Hung, Howard I. Scher, Michael E. Jung, Charles L. Sawyers	1689
10	Direct Rel/Nf-κB Inhibitors: Structural Basis for Mechanism of Action 2009 ·Future Medicinal Chemistry ·Samedy Ouk, Mei-Ling Liou, Hsiou‐Chi Liou	10
11	A novel small molecule CFTR inhibitor attenuates HCO₃⁻ secretion and duodenal ulcer formation in rats 2005 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Yasutada Akiba, Michael Jung, Samedy Ouk, Jonathan D. Kaunitz	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact